Brief: Sinopharm Group Posts Qtrly Net Profit Attributable RMB328 Million For Sinopharm Accord
April 24 (Reuters) - Sinopharm Group Co Ltd 1099.HK: Q1 REVENUE RMB 18,294 MILLION FOR SINOPHARM ACCORD QTRLY NET PROFIT ATTRIBUTABLE RMB328 MILLION FOR SINOPHARM ACCORD Further company coverage: 1099.HK ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For